Please use this identifier to cite or link to this item:
Title: Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP.
Authors: Dhillon, OS
Narayan, HK
Quinn, PA
Squire, IB
Davies, JE
Ng, LL
First Published: Jun-2011
Citation: AM HEART J, 2011, 161 (6), pp. 1163-1170
Abstract: Soluble ST2 is a marker of biomechanical strain for which the natural ligand is interleukin 33 (IL-33). They have not been studied together in non-ST-elevation myocardial infarction (NSTEMI). We investigated their relationship with death, heart failure (HF) readmission, and reinfarction combined (termed major adverse cardiac events [MACE]) and, separately, in unselected patients using Global Registry of Acute Coronary Events Risk Scoring (GRACE-RS) and n terminal pro B type natriuretic peptide (NT-proBNP) as benchmark comparators.
DOI Link: 10.1016/j.ahj.2011.03.025
eISSN: 1097-6744
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Cardiovascular Sciences

Files in This Item:
There are no files associated with this item.

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.